Celltrion Gets Ready To Push Tocilizumab Into Phase III

Korean Company Offers Latest Details On Plans For Actemra/RoActemra Biosimilar

 
• By David Wallace
Clinical Trial Icon
Celltrion’s CT-P47 candidate is ready to enter Phase III trials • Source: Shutterstock

More from Biosimilars

More from Products